Families File Suit to Continue Gender Experiments on Their Children

In an escalation of California’s radical gender ideology agenda clashing with federal efforts to protect children, four families have filed a class-action lawsuit against Rady Children’s Health, demanding the hospital resume and permanently maintain so-called “gender-affirming” care, including puberty blockers and cross-sex hormones, for transgender-identifying minors.

As previously reported, Rady Children’s Health made the difficult but responsible decision in late January 2026 to halt these experimental procedures for patients under 19. The move came directly in response to President Donald Trump’s executive order, “Protecting Children from Chemical and Surgical Mutilation,” which rightly condemns the maiming and sterilizing of impressionable youth under the false banner of “transitioning.” The order threatens to withhold federal funding, including Medicaid and Medicare reimbursements, from institutions that continue these life-altering interventions. This puts not just the targeted children at risk, but the hospital’s ability to serve all its patients.

California Attorney General Rob Bonta, ever the activist, responded by filing suit against Rady on January 30, 2026, claiming the hospital violated conditions of its 2024 merger with Children’s Hospital of Orange County (CHOC). Those conditions, imposed by Bonta himself, bizarrely require Rady to maintain the full scope of “gender services” until at least 2034. San Diego Superior Court Judge Matthew Braner sided with the state, issuing and extending a temporary restraining order that forces Rady to keep providing non-surgical interventions like hormone therapy and puberty blockers—at least through mid-March. The judge called it an “extraordinarily thorny issue,” but the real thorn is California’s stubborn refusal to prioritize child safety over ideology.

Now comes the latest chapter in this saga. Earlier this month, four San Diego-area families, representing minors identified only by initials, filed their proposed class-action complaint in San Diego County Superior Court. The suit, brought with the help of the National Center for Lesbian Rights (NCLR), the Western Center on Law & Poverty, and the Impact Fund, alleges that Rady’s decision to scale back these controversial treatments discriminates against transgender children on the basis of sex, gender identity, and disability (gender dysphoria). They claim it violates multiple California laws that define “gender-affirming” interventions as “medically necessary” and bans discrimination based on gender identity.

The families assert the cutoff has already caused harm to roughly 1,900 patients through canceled appointments, interrupted access to medications, and emotional distress. They are seeking a court injunction to prevent Rady from ever ending these services for minors, plus monetary damages. Shannon Minter, legal director for NCLR, framed the lawsuit in typical activist fashion: “We can’t just as a society stand by silently and passively while hospitals… make decisions to exclude an entire group of people just based on who they are. That sets such a dangerous precedent.”

What’s dangerous, of course, is continuing to push unproven, irreversible treatments on children whose bodies and brains are still developing. European nations like Sweden, Finland, and the UK have sharply restricted or banned these interventions for minors after independent reviews exposed the weak evidence base and serious risks—including infertility, bone density loss, sexual dysfunction, and lifelong medical dependence. Even here in America, growing numbers of detransitioners are coming forward with heartbreaking stories of regret after being rushed down this path.

Rady’s leadership deserves credit for trying to align with federal policy and protect the hospital’s viability. Complying with Trump’s order isn’t “discrimination.” It’s common sense and a safeguard for the very children California claims to champion. The merger conditions Bonta imposed now look less like consumer protection and more like ideological blackmail, especially as federal investigators have already subpoenaed Rady.

This new lawsuit by activist families only underscores the divide: on one side, parents and advocates desperate to keep the experimental pipeline open; on the other, a president, a growing body of science, and millions of concerned Californians who recognize that “affirming” a child’s confusion with drugs and hormones is not “healthcare” but rather harm.

The Rady saga is far from over, with Bonta’s suit still pending and this fresh class action just getting started. One can only hope that cooler heads, ones focused on actual child protection, prevail before more young lives are irreversibly altered in the name of progressive dogma. California’s children deserve better than to be pawns in this dangerous experiment.